Spondylolisthesis, a formidable spinal condition characterized by the slippage of one vertebra over the one below it, represents a significant global health burden. It is a source of chronic, debilitating low back pain, neurological deficits, and reduced quality of life for millions. Historically, the management of spondylolisthesis, which affects an estimated 6-8% of the adult population, with a higher prevalence of degenerative cases in women and older adults, has evolved from conservative care to complex, high-stakes surgical interventions.
The core challenge in treating symptomatic spondylolisthesis lies in achieving three critical goals: decompressing the comp...
